Ab Astrazeneca serves as Executive at Regulus Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Ab Astrazeneca has executed 2 insider transactions totaling $44.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 1, 2017 involved selling 500,000 shares valued at $10.7M.
Ab Astrazeneca currently holds 508,141 shares of Regulus Therapeutics Inc. (RGLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ab Astrazeneca has been a net seller of RGLS stock. They have purchased $0 and sold $44.7M worth of shares.
Ab Astrazeneca's most recent insider trade was on Dec 1, 2017, when they sold 500,000 shares at $21.40 per share.
Get notified when new Form 4 filings are submitted
| $17.00 |
| Discretionary |